"Transparency and Trust: Sharing Our Research Findings"
Trial Result
“Read all our press releases to keep up with our journey.”
We are committed to transparency in our research. Access detailed results from each phase of our clinical trials, including safety data, efficacy rates, and immunogenicity assessments.
Phase I Results: Safety profile and dosage findings.
Phase II Results: Immunogenicity and preliminary efficacy.
Phase III Results: Large-scale efficacy and safety outcomes.
“Our data is your assurance of the rigor and effectiveness of Equivac.”
Safety Data
Our team regularly publishes articles on topics related to vaccine research, global health, and the fight against malaria. These pieces provide insights into our work, the challenges we face, and the solutions we are developing.
“The Role of Vaccines in Achieving Malaria Elimination”
“Addressing the Challenge of Malaria Drug Resistance with Novel Vaccines”
“Browse through our articles for expert perspectives on malaria prevention.”
Efficacy Data
Explore the efficacy of the Equivac Malaria Vaccine across different populations, including high-risk groups such as children under five. Our data shows significant reductions in malaria incidence and severity among vaccinated participants.
“See how Equivac is making a difference in the fight against malaria.”
